Commercial Considerations for IP - and how to make money from your R&D
Join Marks & Clerk and Turing Innovation Catalyst for a seminar on protecting your AI creations through intellectual property (IP). This session will guide you through patents, trademarks, copyrights, and design rights specific to AI.
We'll cover essential commercial IP considerations, including using non-disclosure agreements (NDAs) and maintaining confidentiality in collaborations, becoming investor-ready, managing AI training data, and navigating AI-generated output ownership. Learn diverse routes to market to maximise your innovations.
Finally, discover financial incentives for R&D-focused companies and how to maximise returns on your efforts.
Equip yourself with the knowledge and tools to protect, commercialise, and profit from your AI innovations.
David is recognised as a leading practitioner for digital technologies and as an “outstanding specialist for machine learning patents”.
Marcus is an intellectual property lawyer at Marks & Clerk Law who advises clients on a wide range of IP rights, with a focus on patent litigation in the life sciences sector.
James is a dual-qualified patent attorney working in Manchester's software and electronics patent team. He assists with various aspects of the team's work including the drafting patent specifications and the prosecution of patents at the EPO, UKIPO and abroad.
No.1 Circle Square, Oxford Road, Manchester, M1 7FS
Upcoming events
Business Breakfast: Energy Transition 40
The 40th edition of the Chamber’s Energy Transition survey – sponsored by KPMG and ETZ – has been tracking trends in the UK energy sector for two decades.
Read more
ADIPEC 2024
ADIPEC is the world’s largest and most inclusive gathering for the energy industry, taking place from 4-7 November 2024 in Abu Dhabi.
Read more
Pharma & Biotech Patent Litigation Summit North America
This industry-driven event has been meticulously curated in collaboration with in-house counsels from pharmaceutical, biopharmaceutical, generic and biosimilar organizations. The focus? Identifying cutting-edge trends in international patent litigation that are shaping global pharma and biotech strategy.
Read more